Statins Under Scrutiny
A deep dive into the controversial history of statins reveals significant concerns about their efficacy and safety. Marianne highlights the reluctance of the CTT collaboration to share raw data on statin side effects, raising questions about the influence of pharmaceutical funding. With a stark contrast in trial outcomes before and after 2004, skepticism about the long-held belief in statins as a panacea for cardiovascular disease is warranted.In this clip
From this podcast
Paul Saladino MD podcast
STATINS: Should you take them?
Related Questions